Roche Sequencing Solutions, Inc.
$491.0K 4 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Antares Pharma, Inc.
Antares Pharma, Inc. reported $489,456.23 across General Payments, Research, and Ownership to 19,224 physicians and teaching hospitals across 19,224 transactions.
- $489.5K
- All-tracks total
- 19,224
- Transactions
- 19,224
- Recipients
- −$218.1K
- General Payments vs PY2023
Antares Pharma, Inc. reported $489,456.23 across all CMS Open Payments tracks (General + Research + Ownership) to 19,224 physicians and teaching hospitals in Program Year 2024 - ranking #767 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $489,456.23, averaging $25.46 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer antares-pharma-inc Antares Pharma, Inc.
$489.5K · #767/1,925 · 0.0% industry · PY2024
- TOT $489.5K
- RANK #767
- SHARE 0.0%
- TXN 19,224
- RCP 19,224
- CAT 5
- GEN $489.5K
- ΔGEN −$218.1K
- TOP1 8.5%
- PY 2024
Volume peers
Nearest volume peer: Roche Sequencing Solutions, Inc. ($491.0K)
Antares Pharma, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Antares Pharma, Inc.'s CMS-reported General Payments decreased by $218.1K (−30.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ANTARES PHARMA, INC.PY2023: ANTARES PHARMA, INC.PY2024: Antares Pharma, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $707,579.01
- PY2024
- $489,456.23
What the Data Shows for Antares Pharma, Inc.
In Program Year 2024, Antares Pharma, Inc. reported $489,456.23 in payments to 19,224 physicians and teaching hospitals across 19,224 individual transactions, an average of $25.46 per transaction and $25.46 per recipient. That total places Antares Pharma, Inc. at rank #767 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 5 general-payment categories charted below, "Food and Beverage" is the largest at $365.8K across 19,159 transactions, 74.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 5 types of general payments, Antares Pharma, Inc.'s largest category was "Food and Beverage" at $365.8K - 74.7% of General Payments.
Antares Pharma, Inc. reports 5 general-payment categories - the top three are Food and Beverage (74.7%), Consulting Fee (12.5%), and Honoraria (11.6%). The remaining 2 categories make up 1.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Antares Pharma, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $365.8K | 19,159 | 74.7% |
| Consulting Fee | $61.0K | 9 | 12.5% |
| Honoraria | $57.0K | 23 | 11.6% |
| Travel and Lodging | $5.1K | 9 | 1.0% |
| Compensation for Services Other Than Consulting | $586.64 | 24 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $102,041.66 (20.8%) of $489,456.23 in this company's General Payments records across 7,978 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Antares Pharma, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Carrie Brownstein
$41,687.50 across 5 reported transactions
- 2
Neel Parekh
$18,536.07 across 17 reported transactions
- 3
Ashley Tapscott
$15,488.18 across 25 reported transactions
- 4
Keith Regets
$14,541.66 across 15 reported transactions
- 5
Faysal Yafi
$11,788.25 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Antares Pharma, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Antares Pharma, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Antares Pharma, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Theratechnologies Inc.
$486.8K 3,100 recipients
Compare payment profiles
Royal Biologics, Inc.
$492.4K 287 recipients
Compare payment profiles
Keystone Dental Inc.
$492.7K 2,005 recipients
Compare payment profiles
Prismatik Dentalcraft, Inc.
$485.7K 149 recipients
Compare payment profiles
Dilon Technologies, Inc.
$494.5K 1,797 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.